NO20091231L - Polymorf av (R)-3-(2-hydroksy-2, 2-difenyl-acetoksy)-1-(isoksazol-S-ylcarbamoyl-metyl)-1-azoni A-bicyklo-[2,2,2]oktanbromid - Google Patents

Polymorf av (R)-3-(2-hydroksy-2, 2-difenyl-acetoksy)-1-(isoksazol-S-ylcarbamoyl-metyl)-1-azoni A-bicyklo-[2,2,2]oktanbromid

Info

Publication number
NO20091231L
NO20091231L NO20091231A NO20091231A NO20091231L NO 20091231 L NO20091231 L NO 20091231L NO 20091231 A NO20091231 A NO 20091231A NO 20091231 A NO20091231 A NO 20091231A NO 20091231 L NO20091231 L NO 20091231L
Authority
NO
Norway
Prior art keywords
ylcarbamoylmethyl
diphenylacetoxy
isoxazol
bicyclo
hydroxy
Prior art date
Application number
NO20091231A
Other languages
English (en)
Norwegian (no)
Inventor
Stephanie Monnier
Gerhard Muhrer
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20091231L publication Critical patent/NO20091231L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Otolaryngology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
NO20091231A 2006-08-31 2009-03-24 Polymorf av (R)-3-(2-hydroksy-2, 2-difenyl-acetoksy)-1-(isoksazol-S-ylcarbamoyl-metyl)-1-azoni A-bicyklo-[2,2,2]oktanbromid NO20091231L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06119883A EP1900737A1 (fr) 2006-08-31 2006-08-31 Polymorphe de (R)-3-(2-hydroxy-2,2-diphenyl-acetoxy)-1-(isoxazol-3-ylcarbamoyl-methyl)-1-azonia-bicyclo-[2.2.2]octane bromide
PCT/EP2007/007560 WO2008025541A1 (fr) 2006-08-31 2007-08-29 Polymorphe du bromure de (r)-3-(2-hydroxy-2,2-diphényl-acétoxy)-1-(isoxazol-3-ylcarbamoyl-méthyl)-1-azonia-bicyclo-[2.2.2]octane

Publications (1)

Publication Number Publication Date
NO20091231L true NO20091231L (no) 2009-03-25

Family

ID=37685707

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20091231A NO20091231L (no) 2006-08-31 2009-03-24 Polymorf av (R)-3-(2-hydroksy-2, 2-difenyl-acetoksy)-1-(isoksazol-S-ylcarbamoyl-metyl)-1-azoni A-bicyklo-[2,2,2]oktanbromid

Country Status (21)

Country Link
US (1) US20090264461A1 (fr)
EP (2) EP1900737A1 (fr)
JP (1) JP2010501611A (fr)
KR (1) KR20090051110A (fr)
CN (1) CN101506205A (fr)
AR (1) AR062582A1 (fr)
AU (1) AU2007291515A1 (fr)
BR (1) BRPI0716205A2 (fr)
CA (1) CA2660983A1 (fr)
CL (1) CL2007002524A1 (fr)
GT (1) GT200900044A (fr)
IL (1) IL196808A0 (fr)
MA (1) MA31412B1 (fr)
MX (1) MX2009002300A (fr)
NO (1) NO20091231L (fr)
PE (1) PE20080985A1 (fr)
RU (1) RU2009111390A (fr)
TN (1) TN2009000069A1 (fr)
TW (1) TW200817399A (fr)
WO (1) WO2008025541A1 (fr)
ZA (1) ZA200900449B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR044134A1 (es) * 2003-05-02 2005-08-24 Novartis Ag Derivados de quinuclidina, metodo de preparacion y composiciones farmaceuticas.
SI2091537T1 (sl) * 2006-11-23 2013-10-30 Sinoxa Pharma Gmbh Farmacevtski sestavki za zdravljenje kapilarne arteriopatije

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR044134A1 (es) * 2003-05-02 2005-08-24 Novartis Ag Derivados de quinuclidina, metodo de preparacion y composiciones farmaceuticas.

Also Published As

Publication number Publication date
US20090264461A1 (en) 2009-10-22
KR20090051110A (ko) 2009-05-20
MA31412B1 (fr) 2010-06-01
RU2009111390A (ru) 2010-10-10
WO2008025541A1 (fr) 2008-03-06
JP2010501611A (ja) 2010-01-21
CN101506205A (zh) 2009-08-12
EP2064210A1 (fr) 2009-06-03
AR062582A1 (es) 2008-11-19
PE20080985A1 (es) 2008-09-05
ZA200900449B (en) 2010-01-27
IL196808A0 (en) 2009-11-18
CL2007002524A1 (es) 2008-07-11
AU2007291515A1 (en) 2008-03-06
MX2009002300A (es) 2009-03-20
TN2009000069A1 (en) 2010-08-19
EP1900737A1 (fr) 2008-03-19
GT200900044A (es) 2012-01-16
CA2660983A1 (fr) 2008-03-06
BRPI0716205A2 (pt) 2013-11-12
TW200817399A (en) 2008-04-16

Similar Documents

Publication Publication Date Title
WO2006014665A3 (fr) Derives d'arylpyrrolidine servant d'antagonistes de nk-1/ssri
MX2007010532A (es) Derivados de amida de acido 1-sulfonil-piperidina-3-carboxilico como inhibidores de 11-beta-hidroxiesteroide deshidrogenasa para el tratamiento de diabetes mellitus tipo ii.
NO20072978L (no) Nye betuinderivater, preparat derav og anvendelse derav
MX2007005644A (es) Pirazolo-pirimidinas 1,4-sustituidas como inhibidores de cinasa.
NO20043531L (no) Indazolforbindelser som er nyttige som proteinkinaseinhibitorer
TW200643013A (en) Pyrazoles
DK2324008T3 (da) Diarylpyrazol som protein kinase inhibitorer
NO20084489L (no) Azolopyrimidiner som inhibitorer av cannabinoid 1 aktivitet
NO20071577L (no) Bifenyloksyiddiksyrederivater for behandling av luftveissykdommer
MX2010005299A (es) Derivados de bis-(sulfonilamino) en terapia 066.
MX2009006401A (es) Derivados de indazol como inhibidores de cinasa para el tratamiento del cancer.
WO2009066152A3 (fr) Inhibiteurs de ssao/vap-1 de type haloallylamines et leurs utilisations
ATE442349T1 (de) Diacylglycerol-acyltransferase-hemmer
BR0313176A (pt) Composições de pirazol úteis como inibidores de gsk-3
NO20073140L (no) Pyrrolopyraziner og pyralopyraziner som er nyttige som inhibitorer av proteinkinaser
NO20062689L (no) Azabisykliske heterosykler som modulatorer for kannabinoidreseptorer
EA200970611A1 (ru) Замещенные пиразолохиназолиновые производные, способ их получения и их применение в качестве ингибиторов киназы
NO20071619L (no) Fremgangsmate for fremstilling av indazol forbindelse
MXPA04007414A (es) Indoles sustituidos como agonistas alfa-1.
CA2665931C (fr) Derives d'hydrobenzamide en tant qu'inhibiteurs de la proteine hsp90
WO2008130879A3 (fr) Dérivés de tétrahydroindole et de tétrahydroindazole
UA97348C2 (en) HETEROCYCLIC NF-kB INHIBITORS
NO20083836L (no) N-hydroksyakrylamidforbindelser
NO20061702L (no) Farmasoytiske sammensetninger og fremgangsmater omfattende kombinasjoner av 2-alkyliden-19-nor-vitamin D derivater og en ostrogen agonist/antagonist
NO20082112L (no) 3-Amino-2-arylpropylazaindoler og deres anvendelse

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application